GLY-230 is an orally active neuroprotective agent that inhibits nonenzymatic glycation and decreases glycated albumin levels. This compound has been shown to lower brain Aβ42 levels, highlighting its potential in mitigating neurodegenerative processes. GLY-230 is suitable for research applications related to metabolic and neurological diseases, including diabetic renal dysfunction.
GLY-230 is an orally active neuroprotective agent that inhibits nonenzymatic glycation and decreases glycated albumin levels. This compound has been shown to lower brain Aβ42 levels, highlighting its potential in mitigating neurodegenerative processes. GLY-230 is suitable for research applications related to metabolic and neurological diseases, including diabetic renal dysfunction.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
